INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹193 Cr | ₹342 Cr | ₹389 Cr | ₹349 Cr | ₹216 Cr |
What is the latest Net Current Assets ratio of INDOCO REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹193 Cr |
| Mar2024 | ₹342 Cr |
| Mar2023 | ₹389 Cr |
| Mar2022 | ₹349 Cr |
| Mar2021 | ₹216 Cr |
How is Net Current Assets of INDOCO REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹193 Cr | -43.52 | |
| Mar2024 | ₹342 Cr | -12.01 | |
| Mar2023 | ₹389 Cr | 11.55 | |
| Mar2022 | ₹349 Cr | 61.76 | |
| Mar2021 | ₹216 Cr | - | |
Compare Net Current Assets of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,032.4 Cr | -0.3% | -12.7% | -21.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -0.3% |
-12.7% |
-21.5% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses